BDO has advised the shareholders of Bond Chemicals Limited, a leading fine chemicals and intermediates distributor on its sale to Calibre Scientific, a portfolio company of StoneCalibre, LLC.

Bond Chemicals is a UK-based company specialising in sourcing and supplying fine chemicals, reagents, and biochemicals for the life sciences industry. Bond Chemicals has a robust global network of manufacturing partners, providing raw materials across the entire drug development process, from pre-clinical stages to commercial launch. The acquisition enhances Calibre Scientific’s ability to provide bespoke sourcing solutions to its customers worldwide and strengthens its presence in the pharmaceutical and life sciences sectors.

 

"We are immensely grateful to the BDO team for their advice and guidance throughout the sale process. The team worked tirelessly on the deal to ensure we received maximum value for the business, delivering an exceptional result which achieves our objectives with a partner who shares our strategic vision.
 
BDO were a joy to work with, clear in their advice and always acted with integrity. We are excited to begin this next chapter and help the business grow further as part of Calibre Scientific. We would highly recommend the team at BDO."
Byron Hughes, Managing Director, Bond Chemicals


"The sale of Bond Chemicals to a US-based buyer is a fantastic deal, creating an exciting opportunity for the company as it looks to strengthen and expand its presence in the chemicals and biochemicals space. We look forward to seeing the success of the combined business in the future."
James Fieldhouse, Deal Advisory Partner - M&A

The BDO project team included:
James Fieldhouse, Chris Cumber and Dominic Eccles (Deal advisory - M&A).
Ian Bingham, Lauren Fletcher, Harry Gosling, Emma Lomas, Helen Stancombe, Thomas Bargielowski, David Brown (Tax).
Lawrence McGinley (SPA Advisory).